XTL BIOPHARMACEUTICALS LTD. Other Expense By Function
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Other Expense By Function of $112.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:OtherExpenseByFunction · last filed 2025-04-30
| Period end | Other Expense By Function 12 month |
|---|---|
| 2024-12-31 | $112.00K 20-F · filed 2025-04-30 |
| 2023-12-31 | $1.06M 20-F · filed 2025-04-30 |
| 2022-12-31 | $1.56M 20-F · filed 2025-04-30 |